miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53

被引:11
|
作者
Zhou, Ping [1 ]
Dong, He [1 ]
He, Shuqian [1 ]
Fang, Lei [1 ]
Jiang, Nan [2 ]
Sun, Qing [1 ]
机构
[1] Shandong Univ, Dept Pathol, Qianfoshan Hosp, 16766 Jingshi Rd, Jinan 250014, Shandong, Peoples R China
[2] Shandong Univ, Sch Med, Dept Pathol, Jinan 250014, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
esophageal squamous cell carcinoma; microRNA-612; TP53; lymph node metastasis; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MIR-612; SUPPRESSES; GENE-EXPRESSION; DOWN-REGULATION; CANCER; MICRORNA; PROFILES; P53; SURVIVAL;
D O I
10.3892/mmr.2017.6808
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) serve an important role in the regulation of gene expression. In the present study, differential expressions of miRNAs were compared between esophageal squamous cell carcinoma (ESCC) tissues and normal esophageal tissues. In combination with miRNA target prediction databases, a significantly increased expression of miR-612 was discovered in ESCC. The relationship between miR-612 and TP53 gene expression and their roles in ESCC invasion and metastasis was further studied by reverse transcription-quantitative polymerase chain reaction and western blotting in EC109 cells and cancer tissues. The EC109 cell invasion and migration were significantly reduced after miR-612 expression was inhibited. The levels of wild type TP53 protein and mRNA were lower in ESCC tissues compared to the normal esophageal epithelium. In addition, the mRNA and protein expression levels were reported as downregulated further in tumors with metastasis than in tumors without. In conclusion, miR-612 is identified as associated with ESCC development and metastasis, likely through the regulation of TP53 expression, which could be a potential therapeutic target.
引用
收藏
页码:1855 / 1863
页数:9
相关论文
共 50 条
  • [1] TP53 Mutations in Esophageal Squamous Cell Carcinoma
    Zhong, Leqi
    Li, Hongmu
    Chang, Wuguang
    Ao, Yong
    Wen, Zhesheng
    Chen, Youfang
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (09):
  • [2] Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus
    Lacerda, C. F.
    Cruvinel-Carloni, A.
    Torres de Oliveira, A. T.
    Scapulatempo-Neto, C.
    Lopez, R. V. M.
    Crema, E.
    Adad, S. J.
    Rodrigues, M. A. M.
    Henry, M. A. C. A.
    Guimaraes, D. P.
    Reis, R. M.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (04) : 1 - 9
  • [3] Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma
    Metheetrairut, Chanatip
    Chotigavanich, Chanticha
    Amornpichetkul, Kanchana
    Keskool, Phawin
    Ongard, Sunun
    Metheetrairut, Choakchai
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (02) : 521 - 533
  • [4] Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinoma
    Len, Chen-Sung
    Wang, Liang-Shun
    Chang, Shi-Chuan
    Chou, Teh-Ying
    Hsu, Wen-Hu
    Liu, Chin-San
    Lee, Mau-Hwa
    Chung, Ming-Yi
    Wei, Yau-Huei
    ONCOLOGY REPORTS, 2012, 28 (01) : 69 - 76
  • [5] Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance
    Niyaz, Madiniyet
    Ainiwaer, Julaiti
    Abudureheman, Abulajiang
    Zhang, Liwei
    Sheyhidin, Ilyar
    Turhong, Abduheny
    Cai, Ren
    Hou, Zhichao
    Awut, Edris
    ONCOLOGY LETTERS, 2020, 20 (02) : 1855 - 1865
  • [6] Extremely High Tp53 Mutation Load in Esophageal Squamous Cell Carcinoma in Golestan Province, Iran
    Abedi-Ardekani, Behnoush
    Kamangar, Farin
    Sotoudeh, Masoud
    Villar, Stephanie
    Islami, Farhad
    Aghcheli, Karim
    Nasrollahzadeh, Dariush
    Taghavi, Noushin
    Dawsey, Sanford M.
    Abnet, Christian C.
    Hewitt, Stephen M.
    Fahimi, Saman
    Saidi, Farrokh
    Brennan, Paul
    Boffetta, Paolo
    Malekzadeh, Reza
    Hainaut, Pierre
    PLOS ONE, 2011, 6 (12):
  • [7] The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
    Omura, Go
    Ando, Mizuo
    Ebihara, Yasuhiro
    Saito, Yuki
    Kobayashi, Kenya
    Fukuoka, Osamu
    Akashi, Ken
    Yoshida, Masafumi
    Asakage, Takahiro
    Yamasoba, Tatsuya
    BMC CANCER, 2017, 17
  • [8] TP53 Y220C Is a Hotspot Mutation in Oropharyngeal Squamous Cell Carcinoma
    van Kempen, Pauline M. W.
    Verdam, Froukje J.
    de Poel, Eyleen
    Braunius, Weibel W.
    de Weger, Roel A.
    van Es, Robert J. J.
    Grolman, Wilko
    Willems, Stefan M.
    PATHOBIOLOGY, 2015, 82 (01) : 21 - 27
  • [9] Development of the TP53 mutation associated hypopharyngeal squamous cell carcinoma prognostic model through bulk multi-omics sequencing and single-cell sequencing
    Zhang, Ying
    Cui, Yue
    Hao, Congfan
    Li, Yingjie
    He, Xinyang
    Li, Wenhui
    Yu, Hongyang
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2025, 91 (01)
  • [10] TP53 codon 72 polymorphism in oral squamous cell carcinoma
    Drummond, SN
    De Marco, L
    Pordeus, ID
    Barbosa, AA
    Gomez, RS
    ANTICANCER RESEARCH, 2002, 22 (6A) : 3379 - 3381